These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1458546)

  • 21. The effect of penetration enhancers on drug delivery through skin: a QSAR study.
    Ghafourian T; Zandasrar P; Hamishekar H; Nokhodchi A
    J Control Release; 2004 Sep; 99(1):113-25. PubMed ID: 15342185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of penetration enhancers for testosterone transdermal delivery from spray formulations.
    Leichtnam ML; Rolland H; Wüthrich P; Guy RH
    J Control Release; 2006 Jun; 113(1):57-62. PubMed ID: 16677734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transdermal drug delivery: from micro to nano.
    Pegoraro C; MacNeil S; Battaglia G
    Nanoscale; 2012 Mar; 4(6):1881-94. PubMed ID: 22334401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced transdermal delivery of atenolol from the ethylene-vinyl acetate matrix.
    Cho CW; Shin SC
    Int J Pharm; 2004 Dec; 287(1-2):67-71. PubMed ID: 15541913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomaterials as novel penetration enhancers for transdermal and dermal drug delivery systems.
    Chen Y; Wang M; Fang L
    Drug Deliv; 2013; 20(5):199-209. PubMed ID: 23763451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using the method of homogenization to calculate the effective diffusivity of the stratum corneum with permeable corneocytes.
    Rim JE; Pinsky PM; van Osdol WW
    J Biomech; 2008; 41(4):788-96. PubMed ID: 18093598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery.
    Kanikkannan N; Kandimalla K; Lamba SS; Singh M
    Curr Med Chem; 2000 Jun; 7(6):593-608. PubMed ID: 10702628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Essential oils and their constituents as skin penetration enhancer for transdermal drug delivery: a review.
    Herman A; Herman AP
    J Pharm Pharmacol; 2015 Apr; 67(4):473-85. PubMed ID: 25557808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absorption enhancers.
    Muranishi S
    Crit Rev Ther Drug Carrier Syst; 1990; 7(1):1-33. PubMed ID: 2257635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidermal lipids and topical drug delivery.
    Hadgraft J; Walters KA; Guy RH
    Semin Dermatol; 1992 Jun; 11(2):139-44. PubMed ID: 1498017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modeling of diffusion with partitioning in stratum corneum using a finite element model.
    Barbero AM; Frasch HF
    Ann Biomed Eng; 2005 Sep; 33(9):1281-92. PubMed ID: 16133933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of transdermal penetration enhancers by high-throughput screening.
    Karande P; Jain A; Mitragotri S
    Nat Biotechnol; 2004 Feb; 22(2):192-7. PubMed ID: 14704682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formulation development of transdermal dosage forms: quantitative structure-activity relationship model for predicting activities of terpenes that enhance drug penetration through human skin.
    Kang L; Yap CW; Lim PF; Chen YZ; Ho PC; Chan YW; Wong GP; Chan SY
    J Control Release; 2007 Jul; 120(3):211-9. PubMed ID: 17582639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transdermal iontophoresis: combination strategies to improve transdermal iontophoretic drug delivery.
    Wang Y; Thakur R; Fan Q; Michniak B
    Eur J Pharm Biopharm; 2005 Jul; 60(2):179-91. PubMed ID: 15939232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo microdialysis for the investigation of drug levels in the dermis and the effect of barrier perturbation on cutaneous drug penetration. Studies in hairless rats and human subjects.
    Benfeldt E
    Acta Derm Venereol Suppl (Stockh); 1999; 206():1-59. PubMed ID: 10605601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of chemical penetration enhancers in transdermal drug delivery--possibilities and difficulties.
    Wiechers J
    Acta Pharm Nord; 1992; 4(2):123. PubMed ID: 1388764
    [No Abstract]   [Full Text] [Related]  

  • 37. Skin permeation of ketotifen applied from stick-type formulation.
    Kimura C; Nakanishi T; Tojo K
    Eur J Pharm Biopharm; 2007 Sep; 67(2):420-4. PubMed ID: 17433642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of transdermal delivery of 6-beta-naltrexol via a codrug linked to hydroxybupropion.
    Kiptoo PK; Hamad MO; Crooks PA; Stinchcomb AL
    J Control Release; 2006 Jun; 113(2):137-45. PubMed ID: 16750868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemical penetration enhancers.
    Lopes LB; Garcia MT; Bentley MV
    Ther Deliv; 2015; 6(9):1053-61. PubMed ID: 26458111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential mechanisms by which a single drink of alcohol can increase transdermal absorption of topically applied chemicals.
    Brand RM; Jendrzejewski JL; Charron AR
    Toxicology; 2007 Jun; 235(3):141-9. PubMed ID: 17467136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.